Patient Recruitment Insights: Alzheimer’s Disease Caregiver Burden Report
More than 7 million people in the United States are affected by Alzheimer’s disease or another dementia. Caregivers play a vital role in determining treatment options for their loved one.
Better facilitating caregivers within the clinical research process is conducive to improved patient outcomes, particularly if the burden of clinical trial participation can be lessened to enable the patient access to innovative therapeutics.
To better understand the barriers caregivers face and in turn, improve patient recruitment and retention in neurodegenerative disease, download our report for insights from a survey of 254 primary caregivers.
Survey Callouts:
- 78% of caregivers had never been informed about a clinical research study
- 60% were motivated to advance clinical research
- 48% reported that home health visits would ease the burden of participating in a trial
